Correlation Between Blood Biomarkers and Postoperative Delirium in Elective Non-Cardiac Surgery.

NCT03915314 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2019-04-16

No results posted yet for this study

Summary

More than 20% of patients over 60 years old develop postoperative delirium following non-cardiac surgery . Delirium increases morbidity and mortality , and may lead to long-term cognitive impairment . The underlying mechanisms behind delirium are not understood , endothelial dysfunction and disruption of the blood brain barrier (BBB ) caused by perioperative systemic inflammation may play a important role in the development of delirium . This study intends to evaluate the relationship between neuroinflammation and postoperative delirium in elderly non-cardiac surgery patients . The results of the study are to identify risk factors and explore the biomarkers most closely linked to each step of the proposed pathway .

Conditions

  • Postoperative Delirium
  • Elective Non-Cardiac Surgery

Interventions

DIAGNOSTIC_TEST

Neuropsychological tests

The investigators do the neuropsychological tests, Mini-Mental score examination (MMSE),Charlson Comorbidity Index(CCI),Quality of Recovery Score - 40 (QoR-40),CAGE Alcoholism Questionnaire,blood albumin、hemoglobin content、ALT、AST、BUN、Cr、1 day before the surgery(baseline);serum biomarkers of endothelial dysfunction,blood brain barrier disruption and neuronal injury to be measured at 2 time points,1 day before the surgery(baseline)and postoperative day 1; Confusion Assessment Method(CAM),Numerical Rating Scale(NRS)once before discharge from PACU and 1、2、3 days after surgery twice a day; QoR-40 1 day after surgery.

Sponsors & Collaborators

  • Xuzhou Medical University

    lead OTHER

Eligibility

Min Age
60 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2020-04-30
Completion
2020-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03915314 on ClinicalTrials.gov